Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability.

IF 2.6 4区 医学 Q2 HEMATOLOGY Thrombosis Journal Pub Date : 2024-07-29 DOI:10.1186/s12959-024-00640-5
Houmei Feng, Danyu Song, Qiang Xu, Xiaohui Cai, Jianru Liu, Yang Zhang, Zhou Zhou
{"title":"Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability.","authors":"Houmei Feng, Danyu Song, Qiang Xu, Xiaohui Cai, Jianru Liu, Yang Zhang, Zhou Zhou","doi":"10.1186/s12959-024-00640-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inherited antithrombin, protein C, and protein S deficiency increase the risk of venous thromboembolism. The presence of defects can be identified by clinical laboratory assays. In most Chinese clinical laboratories, the screening tests for antithrombin, protein C, and protein S deficiency are their activity assays. Ensuring appropriate pre-analytical storage conditions for activity tests is essential. This study aimed to assess the effects of storage conditions on antithrombin, protein C, and protein S activity in frozen plasma.</p><p><strong>Methods: </strong>We collected the remaining plasma of 29 patients. The baseline of antithrombin, protein C, and protein S activity values were tested within 4 h. Then, each sample was sub-packaged into 4 EP tubes, and was stored at -20 °C for 3 days, -20 °C for 7 days, -80 °C for 3 days, and - 80 °C for 7 days, respectively. After thawing, samples were tested by two systems.</p><p><strong>Results: </strong>The percentage deviation of antithrombin and protein C activity assay was<10% compared with the initial values. Protein S activity showed a significant reduction in frozen plasma, with a deviation > 10%. Some samples, initially within the normal range, were classified as abnormal after freezing storage.</p><p><strong>Conclusions: </strong>Our study indicated that antithrombin and protein C remain stable when stored at -20 °C or -80 °C in a week. We argued that Protein S activity is not stable in frozen plasma. The use of frozen-thawed plasma for PS activity assay may result in overdiagnosis of protein S deficiency.</p>","PeriodicalId":22982,"journal":{"name":"Thrombosis Journal","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11285460/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thrombosis Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12959-024-00640-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Inherited antithrombin, protein C, and protein S deficiency increase the risk of venous thromboembolism. The presence of defects can be identified by clinical laboratory assays. In most Chinese clinical laboratories, the screening tests for antithrombin, protein C, and protein S deficiency are their activity assays. Ensuring appropriate pre-analytical storage conditions for activity tests is essential. This study aimed to assess the effects of storage conditions on antithrombin, protein C, and protein S activity in frozen plasma.

Methods: We collected the remaining plasma of 29 patients. The baseline of antithrombin, protein C, and protein S activity values were tested within 4 h. Then, each sample was sub-packaged into 4 EP tubes, and was stored at -20 °C for 3 days, -20 °C for 7 days, -80 °C for 3 days, and - 80 °C for 7 days, respectively. After thawing, samples were tested by two systems.

Results: The percentage deviation of antithrombin and protein C activity assay was<10% compared with the initial values. Protein S activity showed a significant reduction in frozen plasma, with a deviation > 10%. Some samples, initially within the normal range, were classified as abnormal after freezing storage.

Conclusions: Our study indicated that antithrombin and protein C remain stable when stored at -20 °C or -80 °C in a week. We argued that Protein S activity is not stable in frozen plasma. The use of frozen-thawed plasma for PS activity assay may result in overdiagnosis of protein S deficiency.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冷冻储存条件对抗凝血酶蛋白 C 和蛋白 S 活性测定稳定性的影响。
背景:遗传性抗凝血酶、蛋白 C 和蛋白 S 缺乏症会增加静脉血栓栓塞的风险。临床实验室检测可确定是否存在缺陷。在大多数中国临床实验室中,抗凝血酶、蛋白 C 和蛋白 S 缺乏症的筛查试验是其活性测定。确保活性检测的适当分析前储存条件至关重要。本研究旨在评估储存条件对冷冻血浆中抗凝血酶、蛋白 C 和蛋白 S 活性的影响:方法:我们收集了 29 名患者的剩余血浆。然后将每个样本分装到 4 个 EP 管中,分别在 -20 °C 下保存 3 天、-20 °C 下保存 7 天、-80 °C 下保存 3 天和 -80 °C 下保存 7 天。解冻后,用两个系统对样本进行检测:抗凝血酶和蛋白 C 活性检测的偏差率为 10%。结果:抗凝血酶和蛋白 C 活性测定的偏差百分比为 10%,一些最初在正常范围内的样本在冷冻储存后被归类为异常:我们的研究表明,抗凝血酶和蛋白 C 在-20 °C或-80 °C储存一周后仍保持稳定。我们认为,蛋白 S 活性在冷冻血浆中并不稳定。使用冷冻解冻血浆进行 PS 活性检测可能会导致蛋白 S 缺乏症的过度诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thrombosis Journal
Thrombosis Journal Medicine-Hematology
CiteScore
3.80
自引率
3.20%
发文量
69
审稿时长
16 weeks
期刊介绍: Thrombosis Journal is an open-access journal that publishes original articles on aspects of clinical and basic research, new methodology, case reports and reviews in the areas of thrombosis. Topics of particular interest include the diagnosis of arterial and venous thrombosis, new antithrombotic treatments, new developments in the understanding, diagnosis and treatments of atherosclerotic vessel disease, relations between haemostasis and vascular disease, hypertension, diabetes, immunology and obesity.
期刊最新文献
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study. Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19. Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study. Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1